HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2412
https://www.valueinhealthjournal.com/article/S1098-3015(24)02626-3/fulltext
Title :
HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02626-3&doi=10.1016/j.jval.2024.03.2412
First page :
Section Title :
Open access? :
No
Section Order :
10817